Initial studies demonstrated that delivering siRNA via AAV-2-mediated retrograde transport from muscles to spinal motor neurons reduced SOD1 levels in ALS mouse models [142]. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.